Carla Danussi

MD Anderson Cancer Center

Disclosure: Nothing to disclose

Presentation(s):

• GENE-17 - ATRX loss in glioma results in epigenetic dysregulation of the G2/M checkpoint and sensitivity to ATM inhibition

  Sunday, November 24
  9:05 AM – 9:15 AM

• GENE-34 - Therapeutically Targeting Epigenomic and Transcriptional Dysfunction in ATRX-deficient Glioma

  Sunday, November 24
  11:30 AM – 11:40 AM